192184-71-7

Usage

Uses

Used in Pharmaceutical Industry:
6-Hydroxyindole-3-carboxaldehyde is used as a starting material for the synthesis of various indole derivatives and natural products, which have potential applications in the development of pharmaceutical drugs.
Used in Neurological Disorder Treatment:
6-Hydroxyindole-3-carboxaldehyde is used as a therapeutic agent for the treatment of neurological disorders due to its role in the biosynthesis of serotonin, an important neurotransmitter in the human body.
Used in Antimicrobial Applications:
6-Hydroxyindole-3-carboxaldehyde is used as an antimicrobial agent due to its antimicrobial properties, which can be beneficial in the development of new antibiotics and antimicrobial treatments.
Used in Antioxidant Applications:
6-Hydroxyindole-3-carboxaldehyde is used as an antioxidant agent due to its antioxidant properties, which can help protect cells from oxidative damage and have potential applications in the prevention and treatment of various diseases and conditions.

Upstream product

• 2380-86-1 6-hydroxy-1H-indole 
• 68-12-2 N,N-dimethyl-formamide 

Relevant academic research and scientific papers

INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF

The invention provides indole and indoline derivatives and slats thereof, compositions comprising them and uses thereof for the treatment of diseases and disorders.

Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease

The cascade of events that occurs in Alzheimer's disease involving oxidative stress and the reduction in cholinergic transmission can be better addressed by multifunctional drugs than cholinesterase inhibitors alone. For this purpose, we prepared a large number of derivatives of indoline-3-propionic acids and esters. They showed scavenging activity against different radicals in solution and significant protection against cytotoxicity in cardiomyocytes and primary cultures of neuronal cells exposed to H2O2 species and serum deprivation at concentrations ranging from 1 nM to 10 μM depending on the compound. For most of the indoline-3-propionic acid derivatives, introduction of N-methyl-N-ethyl or N-methyl-N-(4-methoxyphenyl) carbamate moieties at positions 4, 6, or 7 conferred both acetyl (AChE) and butyryl (BuChE) cholinesterase inhibitory activities at similar concentrations to those that showed antioxidant activity. The most potent AChE inhibitors were 120 (3-(2-aminoethyl) indolin-4-yl ethyl(methyl)carbamate dihydrochloride) and 94 (3-(3-methoxy-3-oxopropyl)-4-(((4-methoxyphenyl)(methyl) carbamoyl)oxy)indolin- 1-ium hydrochloride) with IC50s of 0.4 and 1.2 μM, respectively.